Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03799835
Title Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients (ALBAN)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab + BCG solution

BCG solution

Age Groups: senior | adult
Covered Countries FRA | ESP | BEL


No variant requirements are available.